Guanhao Biotech(300238.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Guanhao Biotech
300238.SZ
Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis.
1.470 T
300238.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
BiotechnologyIndustry
Industry Ranking58/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.45%C
    • Profit Margin5.08%C
    • Gross Margin76.64%A
  • Growth ScoreC
    • Revenue YoY1.46%C
    • Net Profit YoY-29.58%D
    • Total Assets YoY3.01%C
    • Net Assets YoY1.35%C
  • Cash ScoreB
    • Cash Flow Margin216.77%B
    • OCF YoY1.46%C
  • Operating ScoreC
    • Turnover0.5C
  • Debt ScoreB
    • Gearing Ratio37.13%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Guanhao Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 26.7185 million yuan, a decrease of 4.02%

    Zhitong·
    SZ
    300238
    -2.41%
    Zhitong·
    SZ
    300238
    -2.41%

    Guanhao Biotech: Net profit of 20.4041 million yuan in the first half of 2025, a year-on-year increase of 1.27%

    Zhitong·
    SZ
    300238
    -2.41%
    Zhitong·
    SZ
    300238
    -2.41%

    Biological vaccine stocks strengthened, among which, Shen Lian Biomedical rose over 10%, Global Printing 10CM hit the daily limit, Guanhao Biotech and Sinovac Biotech rose over 7%, Saili Medical rose over 5%, Kanglao Weishi, Jinhe Biotechnology, and Vland Biotech rose over 4%, Yongshun Biotech, Dezhan Health, Junzheng Group, and Kanghua Biotech rose over 3%

    Zhitong·
    SZ
    300238
    -2.41%
    SH
    603739
    0.00%
    SH
    688098
    -1.88%
    Zhitong·
    SZ
    300238
    -2.41%
    SH
    603739
    0.00%
    SH
    688098
    -1.88%

    The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limit

    Zhitong·
    SZ
    002287
    -0.54%
    SH
    600513
    -1.17%
    SH
    600774
    -2.38%
    Zhitong·
    SZ
    002287
    -0.54%
    SH
    600513
    -1.17%
    SH
    600774
    -2.38%

    The medical device sector saw a short-term surge, with JG Development hitting the daily limit

    Zhitong·
    SZ
    300238
    -2.41%
    SH
    688236
    -0.88%
    HK
    01858
    -0.80%
    Zhitong·
    SZ
    300238
    -2.41%
    SH
    688236
    -0.88%
    HK
    01858
    -0.80%
    © 2026 Longbridge｜Disclaimer